Mohammed Fakhro et al surveyed 278 patients who underwent lung transplantation. The researchers found that while Bronchiolitis obliterans syndrome (BOS) often limits survival rates following lung transplantation, double-lung transplant recipients showed a better chance of survival despite developing BOS compared to single-lung transplant recipients.
Dr Vipin Zamvar, Royal Infirmary of Edinburgh, UK
Edited by Gencho Nachev and Vipin Zamvar
Featured article: Double lung, unlike single lung transplantation might provide a protective effect on mortality and bronchiolitis obliterans syndrome
Aims and scope
Journal of Cardiothoracic Surgery is an open access journal that encompasses all aspects of research in the field of Cardiology, and Cardiothoracic and Vascular Surgery. The journal publishes original scientific research documenting clinical and experimental advances in cardiac, vascular and thoracic surgery, and related fields.
Topics of interest include surgical techniques, survival rates, surgical complications and their outcomes; along with basic sciences, pediatric conditions, transplantations and clinical trials.
Journal of Cardiothoracic Surgery is of interest to cardiothoracic and vascular surgeons, cardiothoracic anaesthesiologists, cardiologists, chest physicians, and allied health professionals.
“In the last three years, we have been increasingly using BioMed Central journals to present our work. This choice is based on a number of factors, including a streamlined online submission process, rigorous peer-review, open access, and relatively short time from submission to publication. As our experiences while publishing in BioMed Central journals such as Journal of Cardiothoracic Surgery have been excellent, and the benefits of open access to our research are obvious, I intend to continue publishing much of our work through BioMed Central.”
Dr Menelaos Karanikolas, Washington University School of Medicine, USA
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Annual Journal Metrics
78 days to first decision for reviewed manuscripts only
65 days to first decision for all manuscripts
120 days from submission to acceptance
15 days from acceptance to publication
1.470 - 2-year Impact Factor
1.403 - 5-year Impact Factor
0.880 - Source Normalized Impact per Paper (SNIP)
0.581 - SCImago Journal Rank (SJR)
249 Altmetric Mentions